Correction to: Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter, Post-Marketing Surveillance in Japan
Crossref DOI link: https://doi.org/10.1007/s40272-018-0291-3
Published Online: 2018-04-10
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kashiwagi, Tomoko
Okada, Yukiko
Nomoto, Ken
Text and Data Mining valid from 2018-04-10
Article History
First Online: 10 April 2018